Corbus Pharmaceuticals
CRBP
CRBP
107 hedge funds and large institutions have $486M invested in Corbus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
19.27% more ownership
Funds ownership: 81.31% → 100.59% (+19%)
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
22% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $1.52M
Holders
107
Holding in Top 10
6
Calls
$1.19M
Puts
$1.52M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$18.4M | |
| 3 | +$14.3M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$10.2M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$9.76M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$11.3M | |
| 3 | -$6.14M | |
| 4 |
Barclays
London,
United Kingdom
|
-$4.23M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$3.95M |